2. 筋萎縮性側索硬化症 Amyotrophic lateral sclerosis Clinical trials / Disease details

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03272503 (ClinicalTrials.gov)	October 27, 2017	31/8/2017	A Clinical Trial of Pimozide in Patients With Amyotrophic Lateral Sclerosis (ALS)	A Phase II Randomized, Placebo-Controlled, Double Blinded, Multi-Centre Clinical Trial of Pimozidein ...	ALS;Amyotrophic Lateral Sclerosis	Drug: Pimozide 2mg/day (current) or 4 mg/day (study initiation);Drug: Placebo Oral Tablet	University of Calgary	ALS Canada;Brain Canada	Recruiting	18 Years	N/A	All	100	Phase 2	Canada
2	NCT02463825 (ClinicalTrials.gov)	April 2015	21/4/2015	A Registry-Based Clinical Trial of Pimozidein Patients With Neuromuscular Junction Transmission Dysf ...	A Registry-Based Randomized-Controlled, Double-Blinded Clinical Trial of Pimozidein Patients With Ne ...	Amyotrophic Lateral Sclerosis (ALS)	Drug: Pimozide 2 mg per day;Drug: Pimozide 4 mg per day;Drug: Placebo (Lactose tablet)	University of Calgary	Hotchkiss Brain Institute, University of Calgary	Active, not recruiting	18 Years	N/A	Both	25	Phase 2	Canada

First Previous1Next Last